Stocktoria
MYRIAD GENETICS INC MYGN
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-06
MYRIAD GENETICS INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 15,150,806 | $370.6M |
| MILLENNIUM MANAGEMENT LLC | 6,668,817 | $30.0M |
| D. E. Shaw & Co., Inc. | 4,499,724 | $20.2M |
| AQR CAPITAL MANAGEMENT LLC | 1,912,296 | $8.6M |
| TWO SIGMA INVESTMENTS, LP | 1,284,050 | $5.8M |
| Point72 Asset Management, L.P. | 957,901 | $4.3M |
| CITADEL ADVISORS LLC | 490,842 | $2.2M |
| RENAISSANCE TECHNOLOGIES LLC | 454,374 | $2.0M |
Source: SEC EDGAR filings · CIK 0000899923 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.